KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Non-Current Deferred Tax Liability (2016 - 2025)

Boston Scientific's Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $200.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 9.91% year-over-year to $200.0 million; the TTM value through Dec 2025 reached $200.0 million, down 9.91%, while the annual FY2025 figure was $200.0 million, 9.91% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $200.0 million at Boston Scientific, down from $222.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $310.0 million in Q4 2021 and bottomed at $91.0 million in Q3 2023.
  • The 5-year median for Non-Current Deferred Tax Liability is $200.0 million (2025), against an average of $191.3 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability tumbled 80.34% in 2021 before it surged 130.43% in 2022.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $310.0 million in 2021, then tumbled by 51.29% to $151.0 million in 2022, then decreased by 11.26% to $134.0 million in 2023, then surged by 65.67% to $222.0 million in 2024, then fell by 9.91% to $200.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Non-Current Deferred Tax Liability are $200.0 million (Q4 2025), $222.0 million (Q4 2024), and $132.0 million (Q2 2024).